TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
4月 21, 2026
2 min read
60

A U.S. federal judge has delayed Purdue Pharma's criminal sentencing by one week to April 28, citing the need for public participation. The decision came after victims of the opioid crisis appeared in court. The hearing was set to finalize a 2020 guilty plea, which includes a $3.5 billion criminal fine and $2 billion in criminal forfeiture for the company's role in the opioid epidemic.
This sentencing is a critical step toward completing Purdue's bankruptcy settlement. The plan involves dissolving the company and using its assets to establish a $7.4 billion fund for those harmed by the crisis. The agreement, reached with the Department of Justice, directs most of the company's remaining assets to creditors, primarily state and local governments, rather than paying the full federal fines.
Under the 2020 plea deal, Purdue admitted to charges of defrauding the government and paying illegal kickbacks to doctors. As part of the bankruptcy proceedings, the federal government will receive only $225 million of the imposed penalties. Purdue's owners, members of the Sackler family, are contributing a minimum of $6.5 billion to fund the overall settlement, which will support opioid abatement and treatment programs.
The court will reconvene to allow victims to voice their experiences in person before finalizing the sentence. This delay underscores the human element in a landmark corporate criminal case. The outcome will pave the way for distributing settlement funds intended to address the nationwide public health crisis.
Q: Why was Purdue Pharma's sentencing delayed?
A: The sentencing was postponed to allow victims and members of the public who appeared at the courthouse to be heard in person.
Q: What is the total criminal penalty Purdue Pharma faces?
A: The company faces a $3.5 billion criminal fine and $2 billion in criminal forfeiture, though most of this amount will be waived to pay other creditors under the bankruptcy plan.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles